Blog

2 May, 2023

Farmaindustria assures that the revision of the European pharmaceutical legislation “puts the future of the industry at risk”

In the opinion of the employers’ association, it “represents yet another barrier to patient access to innovative treatments” Source: espaciosanitario.com Following the proposed revision of the […]
24 April, 2023

“It’s time for Europe to make up for lost ground in pharmaceutical innovation”

Farmaindustria brings together in Spain the main European National Associations representing the innovative pharmaceutical industry and the European Federation of the Pharmaceutical Industry together with the […]
17 April, 2023

Fifteen organisations sign up to the Code on Data Protection in Clinical Trials in its first year

Farmaindustria states that it is “the first sectoral code approved by the AEPD and a reference at European level” Source: espaciosanitario.com Farmaindustria has announced that a […]
13 March, 2023

Spain authorised more than 900 clinical trials with medicines in 2022, according to the Spanish Clinical Trials Register (REEC). These figures exceed those recorded in the years prior to the pandemic

Source: elperiodico.com Multiple sclerosis is an autoimmune disease of the central nervous system that affects the brain and spinal cord. It is caused by damage to […]
8 March, 2023

Paediatric clinical trials to grow by 24% by 2022, with special focus on cancer and nervous system diseases

Data from the Spanish Clinical Trials Register reveal the commitment of the pharmaceutical industry, which finances 88% of trials with paediatric patients. Incentives for innovation are […]
21 February, 2023

Promoting R&D, equity, access and measurement of health outcomes, priorities for the pharmaceutical industry in the fight against cancer

Oncology is one of the key issues on the health agenda that Spain will take to the Presidency of the Council of the European Union in […]
13 February, 2023

“It is necessary to establish a system of early access to drugs that provide greater clinical benefit to cancer patients”

Farmaindustria’s Director of Access, Isabel Pineros, analyses the current challenges of access to therapeutic innovation at the Spanish Summit against Cancer, organised by Gepac “We must […]
6 February, 2023

HM Hospitales puts the number of patients in clinical trials of its Research Foundation in 2022 at “almost 1,300”.

Three times the number of three years ago Source: actasanitaria.com The health group HM Hospitales has reported that “almost 1,300” patients participated in 2022 in clinical […]
30 January, 2023

The pharmaceutical industry reaches a record figure for research and development of new medicines

2021 closes with the best R&D investment figures ever: the pharmaceutical industry allocates 1,267 million euros to both private and public projects. Source: elespanol.com Investing in […]
23 January, 2023

Pharmaceutical industry launches project to promote patient participation in cross-border clinical trials in the EU

The project is called Borders should no longer be barriers and has been promoted by Efpia and the European Good Clinical Practice Forum, in collaboration with […]
17 January, 2023

Spain registers more than 900 clinical trials in 2022, above pre-pandemic levels

25% of the studies authorised last year are already for orphan drugs to combat rare diseases 86% of trials are driven by the pharmaceutical industry Javier […]
10 January, 2023

“Spain is one of the European countries with the greatest potential for the manufacture of medicines”

The pharmaceutical industry in Spain has a total of 103 production plants, a figure that rises to 173 when active ingredients and veterinary medicines are added […]